1995
DOI: 10.1007/bf00181873
|View full text |Cite
|
Sign up to set email alerts
|

Effects of thromboxane A2 analogue on vascular resistance distribution and permeability in isolated blood-perfused dog lungs

Abstract: This study was designed to determine the effects of thromboxane A2 (TxA2) on the distribution of vascular resistance, lung weight, and microvascular permeability in isolated dog lungs perfused at a constant pressure with autologous blood. The stable TxA2 analogue (STA2; 30 micrograms, n = 5) caused an increase in pulmonary capillary pressure (Pc) assessed as double-occlusion pressure to 14.0 +/- 0.4 mmHg from the baseline of 7.9 +/- 0.3 mmHg with progressive lung weight gain. Pulmonary vascular resistance incr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
9
2

Year Published

1995
1995
2014
2014

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 27 publications
2
9
2
Order By: Relevance
“…The change is accompanied by an increase in pulmonary capillary pressure with progressive lung weight gain. These results suggest that pulmonary veins may play an important role in the development of pulmonary hypertension and edema when TxA 2 production increases (134).…”
Section: Constrictors Of Pulmonary Arteries and Veinsmentioning
confidence: 94%
See 2 more Smart Citations
“…The change is accompanied by an increase in pulmonary capillary pressure with progressive lung weight gain. These results suggest that pulmonary veins may play an important role in the development of pulmonary hypertension and edema when TxA 2 production increases (134).…”
Section: Constrictors Of Pulmonary Arteries and Veinsmentioning
confidence: 94%
“…In a variety of species, including the human, pulmonary veins show a greater sensitivity than arteries to a number of vasoconstrictor stimuli, such as endothelin (ET) (3,13,153,161), platelet-activating factor (PAF; 47, 111, 135), thrombox- ane (71,73,95,113,134,158,165), leukotrienes (14,102,131), and hypoxia (36,53,115,132,155,168) (Table 1). Therefore, in lung disease with hypoxia and/or increased synthesis of these vasoactive agents, venous constriction can aggravate the situation by promoting edema formation.…”
Section: Constrictors Of Pulmonary Arteries and Veinsmentioning
confidence: 99%
See 1 more Smart Citation
“…Because we did not detect overt evidence for hemorrhage, such as blood-stained BAL, or hemorrhagic froth in the airway, the increased lung blood content may reflect a sustained increase of lung blood volume after acid injury. Although mechanisms remain incompletely understood, acid instillation might release arachidonate metabolites, such as thromboxane A 2 , which cause lung venoconstriction (32,33), thereby increasing capillary blood volume. Hence, as proposed previously (34), the present beneficial effects of hyperosmolar sucrose may accrue partially from relief of venoconstriction.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in vitro and ex vivo studies have indicated that thromboxane A 2 not only induces a venous constriction [29,30], but also promotes the formation of pulmonary edema [31]. Moreover, Walch et al [29] studied human pulmonary veins reporting that U46619 induces a constriction 50% higher than that of noradrenaline.…”
Section: Discussionmentioning
confidence: 99%